Innovation Insights

The CRISPR decision and the future of biotech patents

Written by Hejab Azam on Feb 16, 2017 6:00:00 PM

An image of a DNA structure modelOn Wednesday, the United States Patent and Trademark Office (USPTO) upheld a series of patents on gene editing technology by the Broad Institute of MIT and Harvard. The patents have been awarded for a DNA altering technique called CRISPR.


Topics: Technology, IP Risk, Patents, Litigation,, R&D, Healthcare, Patentability, Legal, news

Pharmaceutical vs Biotech: Chemistry vs Biology

Written by Hejab Azam on Jan 12, 2017 11:00:00 AM

Headline image showing a plant growing from a test tube

There is often confusion between biotechnology and pharmaceuticals; although they both produce drugs, they do so in different ways and have a different basis. To manufacture drugs, biotech companies use live organisms such as bacteria whereas pharmaceutical industry usually use artificial materials to create their drugs.


Topics: R&D, Healthcare, Patentability

How to Innovate without Freedom To Operate!

Written by Joe Bamsey on Nov 30, 2016 1:00:00 PM

 Freedom to Operate (FTO) analysis invariably begins by searching patent literature for issued or pending patents, and obtaining a legal opinion as to whether a product, process or service may be considered to infringe any patent(s) owned by others.


Topics: IP & Innovation, Patents, Patentability, FTO

America: The land of the free, and the home of the software patent?

Written by Duncan Clark on Nov 4, 2016 3:39:01 PM

As a result of the Alice Corporation vs CLS Bank ruling, software patents are taking center stage in a heated debate which poses important questions about the nature of patent protection and patentability. We analyzed the state of software patents globally, and found that nearly 50% of all software patent filings are made in the USA, and US-based companies dominating the list of top patentees in terms of activity. 


Topics: Patentability, software patents, Legal